`
`UNITED STATES DISTRICT COURT
`DISTRICT OF MASSACHUSETTS
`
`
`
`
`BURROUGHS, D.J.
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to Federal Rule of Civil Procedure 50 and for the reasons set forth in the Court’s
`
`Memorandum and Order, [ECF No. 695], it is hereby ordered that judgment as a matter of law
`
`on invalidity is GRANTED in Defendant Eli Lilly and Company’s favor, and all asserted claims
`
`of U.S. Patent Nos. 8,586,045, 9,884,907, and 9,884,908 are therefore invalid.
`
`Moreover, under Federal Rule 50(c)(1), “[i]f the court grants a renewed motion for
`
`judgment as a matter of law, it must also conditionally rule on any motion for a new trial by
`
`determining whether a new trial should be granted if the judgment is later vacated or reversed.”
`
`Fed. R. Civ. P. 50(c)(1). In this case, were the Federal Circuit to vacate this judgment, a new
`
`trial would be warranted because, as explained in the Memorandum and Order, the jury’s verdict
`
`with respect to written description and enablement was against the clear weight of the evidence
`
`presented.
`
`SO ORDERED.
`
`
`
`
`September 28, 2023
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ Allison D. Burroughs
`ALLISON D. BURROUGHS
`U.S. DISTRICT JUDGE
`
`
`
`Civil Action No. 18-cv-12029-ADB
`
`
`
`
`
`
`
`**********
`
`
`*
`
`
`ORDER
`
`TEVA PHARMACEUTICALS
`INTERNATIONAL GMBH and TEVA
`PHARMACEUTICALS USA, INC.,
`
`
`
`
`
`Plaintiffs,
`
`v.
`
`
`
`
`
`
`
`ELI LILLY AND COMPANY,
`
`
`
`
`
`
`Defendant.
`
`
`
`
`
`
`
`
`
`
`
`